The number of fertility treatments increased slightly
In 2024, approximately 14,600 fertility treatments were initiated. According to preliminary data, around 15,600 treatments were initiated in 2025, representing a 7% increase from the previous year.
According to preliminary data, the number of treatments grew in 2025 in both the public sector (+4.9%) and the private sector (+10.2%).
The stronger increase in the private sector is mainly explained by the higher growth in treatments using patients’ own gametes (+3.1% in the public sector and +9.3% in the private sector). Treatments using donated gametes increased by 14.4% in the public sector and by 12.0% in the private sector.
“Kela reimbursement for assisted fertility treatment procedures in private clinics was reinstated on 1 May 2025, which is certainly one factor behind the increase. However, treatment numbers also rose in the public sector, so this doesn’t alone explain the growth,” says Anna Heino, Chief Specialist at THL.
“Other contributing factors include the postponement of childbearing and changes in clinic treatment practices.”
| Year | IVF, own gametes | IVF, donated gametes | IUI, partner gametes | IUI, donated gametes |
|---|---|---|---|---|
| 2006 | 7 839 | 1 075 | 3 652 | 758 |
| 2007 | 7 792 | 1 085 | 3 782 | 822 |
| 2008 | 8 226 | 1 026 | 3 753 | 629 |
| 2009 | 7 836 | 1 176 | 3 730 | 803 |
| 2010 | 8 141 | 1 190 | 4 061 | 956 |
| 2011 | 8 302 | 1 229 | 3 903 | 1 029 |
| 2012 | 8 104 | 1 284 | 3 479 | 1 049 |
| 2013 | 7 835 | 1 279 | 3 278 | 1 155 |
| 2014 | 7 932 | 1 346 | 3 226 | 1 176 |
| 2015 | 8 239 | 1 546 | 3 126 | 1 171 |
| 2016 | 8 387 | 1 506 | 2 936 | 1 125 |
| 2017 | 8 025 | 1 309 | 2 463 | 941 |
| 2018 | 8 342 | 1 531 | 2 601 | 967 |
| 2019 | 7 918 | 1 572 | 2 575 | 1 184 |
| 2020 | 7 405 | 1 619 | 2 605 | 1 198 |
| 2021 | 8 768 | 2 045 | 2 992 | 1 503 |
| 2022 | 8 146 | 1 927 | 3 047 | 1 533 |
| 2023 | 8 247 | 1 970 | 2 745 | 1 537 |
| 2024 | 8 262 | 1 880 | 2 896 | 1 568 |
| 2025 | 9 091 | 2 171 | 2 641 | 1 723 |
“The total number of fertility treatments remained relatively stable throughout the 2010s, but the COVID‑19 epidemic and the expansion of treatments using donated gametes in the public sector caused changes in treatment volumes, particularly in 2020–2022. In 2021, the number of treatments was higher, most likely due to clearing the backlog caused by the epidemic,” Heino notes.
According to preliminary data, the number of treatments using donated gametes increased by 13% in 2025 compared with the previous year. The public sector accounted for 41% of treatments using donated gametes in 2025. Based on preliminary data for 2024, the public sector’s share of all fertility treatments was 59%, slightly lower than in 2024.
Nearly 20% of treatments resulted in a birth
Of all fertility treatments initiated in 2024, 19.4% led to a birth, a slightly lower share than in 2023. A total of 2,880 children were born following fertility treatments, accounting for an estimated 6.4% of all births in Finland (6.7% in 2023).
Among all embryo transfers performed in IVF treatments, 29.5% resulted in a birth in 2024. The success rates were nearly identical for transfers using donated gametes (30.0%) and those using patients’ own gametes (29.4%).
The outcomes of insemination treatments were clearly weaker than those of IVF. Of insemination treatments initiated in 2024, 10.4% progressed to a birth.
Success rates decline with increasing maternal age. In IVF treatments, 38.0% of embryo transfers in women under 30 resulted in a birth, compared with 22.6% in women over 40. In insemination treatments, 11.9% of treatments initiated in women under 30 led to a birth, while the corresponding share among women aged 40 or older was 2.8%.
Effective care with new register data
THL’s new national register on assisted fertility treatments began its operation on 1 January 2026. In the next few years, the new register will replace THL’s current aggregate-level data collection on fertility treatments. THL collects assisted fertility treatment cycles-specific data on all fertility treatments performed in Finland to the register on assisted fertility treatments.
The cycle-based register will serve as a key source of information for monitoring the impacts and quality of assisted fertility treatments. The register helps the long-term follow-up of fertility treatments and the children born as a result of them and supports the assessment of the development of treatments in the fertility sector and their cost-effectiveness.
About the data in more detail
- Read the entire statistical report (Julkari)
- Statistics in the database report
- Indicator data in Sotkanet
Background information
- Statistical quality report
- Description of Statistical Data (Data resources catalogue)
- Description of Register Data (Data resources catalogue)
- Instructions for submitting data (in Finnish)
Source
Assisted Fertility Treatments 2024–2025
Statistical Report 15/2026, 21.5.2026.
Official Statistics of Finland, Assisted fertility treatments. THL.
Description of the statistics
The statistic contains information on fertility treatments, the resulting pregnancies, and subsequent births. Figures on fertility treatments are collected annually from all clinics in Finland that provide fertility treatment. They contain information on insemination treatments and test tube fertilisation, as well as treatment with the patient's own, or donated gametes.
The information has been collected since 1992. The data are presented at the national level. Clinic-specific data are not published. The fertility treatment statistics do not contain personal data on assisted fertility treatment recipients.
Update schedule
Assisted fertility treatment statistics are published annually in the spring, at which time the previous year's preliminary data and the preceding year's final data are published.
The more exact publication time can be found in the publication calendar.
Publication calendar for statistics
Contact information
Chief Specialist
tel. 029 524 7177
[email protected]
Research Professor
tel. +358 40 503 3805
[email protected]
Mika Gissler (ResearchGate)